GlobalData on MSN
Lipocine completes Phase III enrolment for LPCN 1154 in PPD
Lipocine expects trial data to support a 505(b)(2) new drug application submission for LPCN 1154 in 2026.
The following scenario emphasizes the necessity of creating a wheal while administering the Mantoux test. A 46-year-old Asian man who recently immigrated to the United States was seen for routine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results